Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Eskilstuna
Clinical trial register · Sweden

Clinical Trials in Eskilstuna, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Sweden and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2219 matching records held by the registry are in this view. Synced 12 Oct 2026, 03:19 UTC
2219
Studies in scope
all four open statuses
1247
Recruiting now
open to new participants
367
Lead sponsors
across recruiting studies
Top sites
Stockholm 930 Gothenburg 631 Lund 404 Uppsala 369 Linköping 236
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Uppsala University5 Sahlgrenska University Hospital2 Karolinska Institutet2 Region Skane2 Halmstad County Hospital1
Site location
Stockholm930 Gothenburg631 Lund404 Uppsala369 Linköping236
All 146 locations
Target enrolment
to

Trials with a site in Eskilstuna

25 of 2219 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Sweden
Start
Recruiting
Treating Emergency Laparotomy Incisions With Negative Pressure Wound Therapy
NCT07003906Surgical Incision, Wound Dehiscence, Surgical Site Infection, Incisional Hernia
Uppsala University
Not applicable
720
Eskilstuna, Linköping, Mora, Norrköping, Uppsala, Västerås
2025-12-16
Recruiting
Uppsala University
Phase 4
560
Borås, Eskilstuna, Gothenburg, Karlskrona, Lund, Örebro, Stockholm, Sundsvall
2025-12
Recruiting
Pfizer
Phase 3
680
Gävle, Eskilstuna, Gothenburg
2025-09-29
Not yet open
Region Örebro County
Phase 3
3,832
Visby, Eskilstuna, Falun, Gävle, Gothenburg, Jönköping, Kalmar, Lund
2025-05-02
Recruiting
Uppsala University
Phase 3
1,792
Eskilstuna, Falun, Gävle, Gothenburg, Jönköping, Kalmar, Karlstad, Linköping
2024-12-19
Recruiting
Sormland County Council, Sweden
Not applicable
160
Eskilstuna
2024-06-27
Recruiting
Eli Lilly and Company
Phase 3
1,264
Eskilstuna, Västerås
2023-12-21
Recruiting
Region Skane
Not applicable
1,850
Danderyd, Eskilstuna, Falun, Gothenburg, Halmstad, Helsingborg, Lund, Malmö
2023-11-27
Recruiting
DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732Unresectable Breast Cancer, Metastatic Breast Cancer, HER2-low Expressing Breast Cancer, HER2-(Ultra)Low Expressing Breast Cancer
DrugTrastuzumab deruxtecan
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,295
Eskilstuna, Gävle, Jönköping, Örebro, Stockholm, Sundsvall, Umeå, Västerås
2023-10-24
Recruiting
GlaxoSmithKline
Phase 3
892
Eskilstuna, Gothenburg, Linköping, Malmö, Stockholm, Uppsala
2023-08-01
Recruiting
Region Skane
Not applicable
1,350
Borås, Eskilstuna, Gävle, Gothenburg, Halmstad, Jönköping, Kalmar, Karlstad
2023-03-17
Recruiting
Transurethral Prostate Resection (TURP) vs. Prostate Artery Embolization (PAE)
NCT05531240Transurethral Resection of Prostate Syndrome, Prostate Hyperplasia, Embolization, Therapeutic
Uppsala University
Not applicable
104
Helsingborg, Eskilstuna, Enköping, Västerås
2022-10-01
Active, closed
Region Västerbotten
Phase 4
212
Eskilstuna, Falun, Gävle, Luleå, Öre, Östersund, Skövde, Stockholm
2022-04-28
Active, closed
HELicobacter Pylori Screening to Prevent Gastrointestinal Bleeding in Patients With Acute Myocardial Infarction
NCT05024864Myocardial Infarction, Helicobacter Pylori Infection, GastroIntestinal Bleeding, Cardiovascular Diseases
Karolinska Institutet
Not applicable
20,000
Borås, Eskilstuna, Falun, Gävle, Gothenburg, Halmstad, Helsingborg, Jönköping
2021-11-17
Active, closed
Onset PrevenTIon of Urinary Retention in Orthopaedic Nursing and Rehabilitation
NCT04700969Urinary Retention, Hip Fractures, Hip Arthritis
Örebro University, Sweden
Not applicable
20
Arvika, Danderyd, Eksjö, Enköping, Eskilstuna, Huddinge, Johanneshov, Karlskoga
2020-12-15
Active, closed
Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT)
NCT04562805Coronary Artery Disease, Ischemic Heart Disease
Elixir Medical Corporation
Not applicable
2,400
Eskilstuna, Halmstad, Helsingborg, Karlskrona, Karlstad, Lund, Malmö, Örebro
2020-09-30
Active, closed
COPE - COVID-19 in Pregnancy and Early Childhood
NCT04433364Sars-CoV2, Covid-19, Pregnancy Complications, Pregnancy Preterm
Sahlgrenska University Hospital
Observational
3,834
Falun, Halmstad, Varberg, Helsingborg, Lund, Eskilstuna, Borås, Gothenburg
2020-06-02
Active, closed
Remote Exercise SWEDEHEART Study
NCT04260958Myocardial Infarction
Sahlgrenska University Hospital
Not applicable
1,500
Borås, Eskilstuna, Falun, Gällivare, Gävle, Gothenburg, Hässleholm, Jönköping
2020-02-03
Recruiting
Halmstad County Hospital
Observational
5,300
Alingsås, Eskilstuna, Gothenburg, Halmstad, Jönköping, Ljungby, Lund, Malmö
2018-04-01
Recruiting
Uppsala University
Not applicable
1,300
Borås, Eskilstuna, Falun, Gävle, Gothenburg, Helsingborg, Jönköping, Kalmar
2017-06-08
Active, closed
Myocardial Injury in Noncardiac Surgery in Sweden
NCT03436238Perioperative/Postoperative Complications, Risk Factor, Cardiovascular
Linkoeping University
Observational
1,269
Kristianstad, Eskilstuna, Jönköping, Lund, Malmö, Norrköping, Linköping
2017-05-15
Active, closed
AstraZeneca
Phase 3
953
Eskilstuna, Linköping, Stockholm, Uppsala
2015-11-03
Active, closed
Trial on Three Treatments for Scoliosis
NCT01761305Idiopathic Scoliosis
Karolinska Institutet
Not applicable
135
Eskilstuna, Jönköping, Linköping, Stockholm, Sundsvall, Umeå, Västerås
2013-01
Active, closed
University Medical Center Groningen
Phase 3
920
Borås, Eskilstuna, Falun, Gävle, Gothenburg, Kalmar, Karlstad, Linköping
2011-06-21
Active, closed
Janssen Scientific Affairs, LLC
Observational
20,167
Eskilstuna, Gothenburg, Kungsbacka, Stockholm
2007-06-21
Rows per page Showing 1–25 of 25
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Swedish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-sweden/city/eskilstuna

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Sweden and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,219 studies in total at the last sync on 12 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 25 of those studies with a site in Eskilstuna.

How many clinical trials are recruiting in Eskilstuna?

13 of the 25 studies on this page are recruiting new participants as of the 12 Oct 2026, 03:19 UTC sync. A further 1 have not yet opened recruitment, 11 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Eskilstuna), 25 studies
PhaseStudiesRecruitingShare
Not applicable11644%
Phase 37428%
Observational5220%
Phase 4218%

Most active sponsors

Lead sponsors with the most studies (Eskilstuna)
Lead sponsorStudiesRecruiting
Uppsala University55
Karolinska Institutet20
Region Skane22
Sahlgrenska University Hospital20
AstraZeneca10
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company11
Eli Lilly and Company11
Elixir Medical Corporation10
GlaxoSmithKline11
Halmstad County Hospital11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.